PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
about
Parturition dysfunction in obesity: time to target the pathobiologyAssociation of variants in genes related to the immune response and obesity with BPH in CLUE IIMechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.Extensive alternative splicing of the repressor element silencing transcription factor linked to cancer.Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus.Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.Coining a new term-Urovesicology: advancing towards a mechanistic understanding of bladder symptoms.The Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms.Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes.Prostatic protective nature of the flavonoid-rich fraction from Cyclosorus acuminatus on carrageenan-induced non-bacterial prostatitis in rat.Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.Metformin: an anti-proliferative agent and methylation regulator in treating prostatic disease?The effect of pomegranate fruit extract on testosterone-induced BPH in rats.
P2860
Q26774719-EF5A5C3D-3D51-429C-A22E-29A0CDE6154CQ34490355-DD52F88F-EA96-441D-8577-185D5C1AEE1AQ34529072-465A4AEA-8024-4896-B63F-02A61E806153Q34685755-6B6601C9-1464-4200-9F3F-CBB5AD74B2ACQ35190607-5970864C-2A67-4C5B-B486-8DBA7A13790AQ35798142-506DAD9B-3A5A-4FC9-935F-F61044A97190Q36211459-80A86D3F-EC6D-409C-80FB-2B2F8E8EDBBDQ36463541-2D0A6AAE-C3B3-44AE-88F2-6C136ACE1D39Q36993287-9D72993A-9A2B-473B-96DC-A51EAAA6628BQ37018606-4DD17C38-F32C-4DA5-AF64-4CBEFE20ED41Q38913900-D2DCC8A7-0146-4C43-B2C5-C6918869936BQ39062508-F4CE5FB9-1C55-445B-819E-E4806A51163CQ40088730-4944DF37-D0E1-45B6-ACC0-6FC215B94611Q40143114-C1FB52C7-9131-44E8-AFED-3C70996665D0Q41871759-19611A1D-1CA2-4F96-A118-3EB41460D3EBQ43568081-67EE2A0F-49FD-4E66-8C1C-AA6DA4CC8C19Q48242893-5AECAF9A-387B-47EB-859B-04BFA192422CQ50103863-6CFBA370-6CE0-4D5E-9728-AAE0E71F39C7Q53635536-317E5051-98DB-4A44-B4BB-EDC394F75C0C
P2860
PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PPARγ: a molecular link betwee ...... d benign prostate hyperplasia.
@ast
PPARγ: a molecular link betwee ...... d benign prostate hyperplasia.
@en
type
label
PPARγ: a molecular link betwee ...... d benign prostate hyperplasia.
@ast
PPARγ: a molecular link betwee ...... d benign prostate hyperplasia.
@en
prefLabel
PPARγ: a molecular link betwee ...... d benign prostate hyperplasia.
@ast
PPARγ: a molecular link betwee ...... d benign prostate hyperplasia.
@en
P2860
P50
P1433
P1476
PPARγ: a molecular link betwee ...... nd benign prostate hyperplasia
@en
P2093
Omar E Franco
P2860
P304
P356
10.1016/J.DIFF.2011.05.008
P577
2011-06-08T00:00:00Z